EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current status of molecular diagnostic approaches using liquid biopsy

Kenji Takahashi, Yohei Takeda, Yusuke Ono, Hajime Isomoto, Yusuke Mizukami

Journal of Gastroenterology · 2023-09 · 58 (9) · 834-847

DOI: 10.1007/s00535-023-02024-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology, online erschienen am 20.07.2023. Verfasst von Kenji Takahashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 2-1 …. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Pancreas Research Foundation of Japan, The Japanese Society of Gastroenterology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal cancers, and developing an efficient and reliable approach for its early-stage diagnosis is urgently needed. Precancerous lesions of PDAC, such as pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasms (IPMN), arise through multiple steps of driver gene alterations in KRAS , TP53 , CDKN2A , SMAD4 , or GNAS . Hallmark mutations play a role in tumor initiation and progression, and their detection in bodily fluids is crucial for diagnosis. Recently, liquid biopsy has gained attention as an approach to complement pathological diagnosis, and in addition to mutation signatures in cell-free DNA, cell-free RNA, and extracellular vesicles have been investigated as potential diagnostic and prognostic markers. Integrating such molecular information to revise the diagnostic criteria for pancreatic cancer can enable a better understanding of the pathogenesis underlying inter-patient heterogeneity, such as sensitivity to chemotherapy and disease outcomes. This review discusses the current diagnostic approaches and clinical applications of genetic analysis in pancreatic cancer and diagnostic attempts by liquid biopsy and molecular analyses using pancreatic juice, duodenal fluid, and blood samples. Emerging knowledge in the rapidly advancing liquid biopsy field is promising for molecular profiling and diagnosing pancreatic diseases with significant diversity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansPathology, MolecularEarly Detection of CancerMutationLiquid Biopsy

Stichwörter der Autor:innen

Gene mutationLiquid biopsyPancreatic cancerPancreatic juiceSecretin

Autor:innen und Institutionen

  • Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido, 078-8510, Japan. t-kenji@asa…
  • Division of Medicine and Clinical Science, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Tottori, Japan.
  • Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido, 078-8510, Japan.
  • Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Pancreas Research Foundation of Japan
  • The Japanese Society of Gastroenterology
  • Princess Takamatsu Cancer Research Fund

Zitieren

APA

Takahashi, K., Takeda, Y., Ono, Y., Isomoto, H., & Mizukami, Y. (2023). Current status of molecular diagnostic approaches using liquid biopsy. Journal of Gastroenterology, 58(9), 834-847. https://doi.org/10.1007/s00535-023-02024-4

Vancouver

Takahashi K, Takeda Y, Ono Y, Isomoto H, Mizukami Y. Current status of molecular diagnostic approaches using liquid biopsy. Journal of Gastroenterology. 2023;58(9):834-847. doi:10.1007/s00535-023-02024-4

BibTeX
@article{Takahashi2023,
  author = {Takahashi, Kenji and Takeda, Yohei and Ono, Yusuke and Isomoto, Hajime and Mizukami, Yusuke},
  title = {Current status of molecular diagnostic approaches using liquid biopsy},
  journal = {Journal of Gastroenterology},
  year = {2023},
  volume = {58},
  number = {9},
  pages = {834--847},
  doi = {10.1007/s00535-023-02024-4}
}
Kostenlos starten →